Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening
MedPage Today) — Studies presented at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid included early data for oral amycretin, safety data for tirzepatide (Mounjaro, Zepbound), and voice screening for diabetes…
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening Read More ยป